Sage Journals: Discover world-class research

Retricted access

Research article

First published 2008-11

Expression of Opioid Growth Factor (OGF)–OGF Receptor (OGFr) Axis in Human Nonmedullary Thyroid Cancer

David Goldenberg, Ian S. Zagon, Fred Fedok [...]

Thyroid®

Retricted access

Research article

First published 2011-9

Low-dose naltrexone targets the opioid growth factor–opioid growth factor receptor pathway to inhibit cell proliferation: mechanistic evidence from a tissue culture model

Renee N Donahue, Patricia J McLaughlin, Ian S Zagon

Experimental Biology and Medicine

Retricted access

Research article

First published 2011-7

Low-dose naltrexone suppresses ovarian cancer and exhibits enhanced inhibition in combination with cisplatin

Renee N Donahue, Patricia J McLaughlin, Ian S Zagon

Experimental Biology and Medicine

Retricted access

Research article

First published 2003-8

10:30 am Continuous Delivery of Opioid Growth Factor (OGF) Inhibits SCCHN

Douglas Chepeha, Terry TerryDay, Ted Teknos [...]

Otolaryngology–Head and Neck Surgery

Retricted access

Research article

First published 2013-5

Targeting the opioid growth factor: Opioid growth factor receptor axis for treatment of human ovarian cancer

Ian S Zagon, Renee Donahue, Patricia J McLaughlin

Experimental Biology and Medicine

Retricted access

Research article

First published 2013-6

Opioid growth factor – opioid growth factor receptor axis inhibits proliferation of triple negative breast cancer

Ian S Zagon, Nancy K Porterfield, Patricia J McLaughlin

Experimental Biology and Medicine

Retricted access

Research article

First published 2018-2

Featured Article: Modulation of the OGF–OGFr pathway alters cytokine profiles in experimental autoimmune encephalomyelitis and multiple sclerosis

Michael D Ludwig, Ian S Zagon, Patricia J McLaughlin

Experimental Biology and Medicine

Retricted access

Research article

First published 2010-11

Inhibition of DNA synthesis in mouse epidermis by topical imiquimod is dependent on opioid receptors

Patricia J McLaughlin, Moshe Rogosnitzky, Ian S Zagon

Experimental Biology and Medicine

Retricted access

Research article

First published 2021-3

Blockade of OGFr delays the onset and reduces the severity of diabetic ocular surface complications

Ian S Zagon, Joseph W Sassani, Indira Purushothaman [...]

Experimental Biology and Medicine

Retricted access

Research article

First published 2014-10

Featured Article: Selective blockade of the OGF–OGFr pathway by naltrexone accelerates fibroblast proliferation and wound healing

Jessica A Immonen, Ian S Zagon, Patricia J McLaughlin

Experimental Biology and Medicine

Search results